Astral Pharmaceuticals Private Limited

Astral Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24231MH2006PTC161708 Incorporated 09 May 2006 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹4.57 Lakh
▲ 50% YoY
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹17.14 Lakh
Issued & subscribed
Company age
20 yrs
Est. 2006
Directors on board
2
As per MCA filings
GST registrations
1
None active
Last financials
Mar 2025
Balance sheet date
Last AGM
30 Sep 2025
Annual general meeting

About Astral Pharmaceuticals Private Limited

Data last updated:

Astral Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 May 2006 and has been in existence for over 20 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24231MH2006PTC161708. The company has 1 GST registration on record, which is no longer active.

The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹17.14 Lakh. It was formerly known as Anovaa Pharma Private Limited. It is led by directors Shyam Sundar Jajodia and Ajaay Shyamsundar Jajodia.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 10 Floor – 2nd Plot – 8 A Pankaj Mansion Dr Annie Besant Road Worli Naka, Mumbai, Maharashtra, India – 400018.

As per the financials filed for FY 2025, the company reported a revenue of ₹4.57 Lakh, a growth of 50% compared to the previous year. Revenue has declined at a compounded annual rate (CAGR) of 58% over three years and 41% over five years.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website astralpharmaceuticals.com.

Company details

CIN U24231MH2006PTC161708
Registration Number 161708
Incorporation Date 09 May 2006
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

CIN history

Astral Pharmaceuticals has one previous CIN (Corporate Identification Number): U24231MH2006PTC161612. The current CIN is U24231MH2006PTC161708, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24231MH2006PTC161708Current
U24231MH2006PTC161612Previous

Contact details

Astral Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is astralpharmaceuticals.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    A – 10 Floor – 2nd Plot – 8 A Pankaj Mansion Dr Annie Besant Road Worli Naka, Mumbai, Maharashtra, India – 400018
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Astral Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Astral Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Astral Pharmaceuticals is other service activities. In detail, this covers activities of membership organizations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
SOther service activities94Activities of membership organizations

To see the full business activity and turnover split of Astral Pharmaceuticals Private Limited, buy the company report.

Financials of Astral Pharmaceuticals Private Limited

FY 2025 filings available

Astral Pharmaceuticals Private Limited reported revenue of ₹4.57 Lakh (up 50% YoY) for FY 2025.

Revenue · FY 2025
₹4.57 Lakh ▲ 50%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 50%
3 years · compounded
▼ 58%
5 years · compounded
▼ 41%

Revenue rose 50% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 41%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Astral Pharmaceuticals Private Limited, buy the company report.

Board of directors of Astral Pharmaceuticals Private Limited

Astral Pharmaceuticals has 2 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Shyam Sundar JajodiaDirector02 Nov 201213 Years 11 MonthsCurrent
Ajaay Shyamsundar JajodiaDirector15 Apr 20224 Years 6 MonthsCurrent

Auditor

Astral Pharmaceuticals Private Limited is audited by YKC AND COMPANY for the financial year 2023.

Auditor firmFinancial yearFirm registration number
YKC AND COMPANYFY 2023136640W

Shareholding

The shareholding of Astral Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Astral Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Astral Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Astral Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Astral Pharmaceuticals Private Limited, buy the company report.

Recent activity

Astral Pharmaceuticals Private Limited has 13 board changes on record since 2010: 2 appointments and 11 cessations. The latest: Ajaay Shyamsundar Jajodia was appointed as Director on 15 Apr 2022.

AGM
Astral Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Astral Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Ajaay Shyamsundar Jajodia was appointed as Director.
Ceased
Sankalp Agrawal Omprakash ceased to be Additional Director.
Ceased
Shrawan Kumar Babulal Jajodia ceased to be Additional Director.
Ceased
Ajaay Shyamsundar Jajodia ceased to be Director.
Ceased
Narottam Ajaay Jajodia ceased to be Director.
Ceased
Gaurav Gopal Agrawal ceased to be Director.
Ceased
Jagruti Gaurav Agrawal ceased to be Director.
Ceased
Rajendra Kumar Kashyap ceased to be Director.
Ceased
Janhavi Anil Salvi ceased to be Director.
Ceased
Anup Murarilal Jhunjhunwala ceased to be Director.

4 earlier events are in the company report.

Frequently asked questions

Astral Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 May 2006 (20+ years old) and is registered under CIN U24231MH2006PTC161708.

Astral Pharmaceuticals has 2 current directors:

The latest financial statements of Astral Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

No. Astral Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.

The CIN (Corporate Identification Number) of Astral Pharmaceuticals is U24231MH2006PTC161708. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Astral Pharmaceuticals was incorporated on 09 May 2006, making it 20+ years old. It is registered with the Registrar of Companies, Mumbai.

Ajaay Shyamsundar Jajodia was appointed as Director on 15 Apr 2022. Sankalp Agrawal Omprakash ceased to be Additional Director on 15 Apr 2022. Shrawan Kumar Babulal Jajodia ceased to be Additional Director on 15 Apr 2022. Astral Pharmaceuticals has 13 board changes on record in total.

Astral Pharmaceuticals can be reached through the website astralpharmaceuticals.com. Its registered office is in Mumbai, Maharashtra, India.

The registered office of Astral Pharmaceuticals is at A – 10 Floor – 2nd Plot – 8 A Pankaj Mansion Dr Annie Besant Road Worli Naka, Mumbai, Maharashtra, India – 400018.

Astral Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.